These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #EndoPath pages here: https://serdarbalci.netlify.com/categories/EndoPath/ or here: https://serdarbalci.wordpress.com/?s=EndoPath/ See selected social media based textbook project here: http://www.patolojinotlari.com/
Medullary carcinoma. Thyroid, thyroidectomy. HE and calcitonin. pic.twitter.com/Q8nl59Nu8E
— Pathology Walker@Auto Tweet Bot (@Patholwalker) March 29, 2020
Clear cell renal cell carcinoma (metastatic). thyroid, hemithyroidectomy. #pathology pic.twitter.com/xTBqf2ouea
— Pathology Walker@Auto Tweet Bot (@Patholwalker) June 25, 2019
Anaplastic thyroid carcinoma (undifferentiated carcinoma). Thyroid, excisional biopsy. #pathology #ENTpath #Endopath
— Pathology Walker@Auto Tweet Bot (@Patholwalker) June 23, 2019
Microcolloid formation of poorly differentiated carcinoma of thyroid gland. #pathology #Endopath pic.twitter.com/1iJMRP5SdP
— Pathology Walker@Auto Tweet Bot (@Patholwalker) September 28, 2018
Solid growth pattern of poorly differentiated carcinoma of thyroid gland. #Endopath #pathology pic.twitter.com/P2yjXGWxwn
— Pathology Walker@Auto Tweet Bot (@Patholwalker) September 28, 2018
Scirrhous growth pattern of poorly differentiated carcinoma of thyroid gland. #pathology #Endopath pic.twitter.com/vijkMNun4e
— Pathology Walker@Auto Tweet Bot (@Patholwalker) September 27, 2018
Trabecular growth pattern of poorly differentiated carcinoma of thyroid gland. #pathology #Endopath pic.twitter.com/rqAY1Lv0VG
— Pathology Walker@Auto Tweet Bot (@Patholwalker) September 27, 2018
New CAPcast: Interpreting Thyroid Nodules: Problems and Controversies. #cap19orl faculty member Dr. Saul Suster discusses controversial areas in thyroid nodule interpretation and recent changes in terminology for papillary carcinoma: https://t.co/mKcXodLup7. #pathologists pic.twitter.com/1Eqj9MyXwv
— CAPathologists (@Pathologists) June 16, 2019
New CAPcast: Interpreting Thyroid Nodules: Problems and Controversies. #cap19orl faculty member Dr. Saul Suster discusses controversial areas in thyroid nodule interpretation and recent changes in terminology for papillary carcinoma: https://t.co/mKcXodLup7. #pathologists pic.twitter.com/W5Mdfe6r4D
— CAPathologists (@Pathologists) June 15, 2019
New CAPcast: Interpreting Thyroid Nodules: Problems and Controversies. #cap19orl faculty member Dr. Saul Suster discusses controversial areas in thyroid nodule interpretation and recent changes in terminology for papillary carcinoma: https://t.co/mKcXodLup7. #pathologists pic.twitter.com/QVNuh6gwi3
— CAPathologists (@Pathologists) June 14, 2019
New CAPcast: Interpreting Thyroid Nodules: Problems and Controversies. #cap19orl faculty member Dr. Saul Suster discusses controversial areas in thyroid nodule interpretation and recent changes in terminology for papillary carcinoma: https://t.co/mKcXodLup7. #pathologists pic.twitter.com/Xl8HHIo7rb
— CAPathologists (@Pathologists) June 13, 2019
New CAPcast: Interpreting Thyroid Nodules: Problems and Controversies. #cap19orl faculty member Dr. Saul Suster discusses controversial areas in thyroid nodule interpretation and recent changes in terminology for papillary carcinoma: https://t.co/mKcXodLup7. #pathologists pic.twitter.com/Yp29y8uTmE
— CAPathologists (@Pathologists) June 12, 2019
These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #EndoPath pages here: https://serdarbalci.netlify.com/categories/EndoPath/ or here: https://serdarbalci.wordpress.com/?s=EndoPath/ See selected social media based textbook project here: http://www.patolojinotlari.com/